Skip to main content

Table 2 Summary of statistical data.

From: Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10

   8F1 D-10  
   CC1-mono H2-60 CC1-mono H2-60  
   Int H Int H Int H Int H Average
A. Score means           
Cell blocks   2.10 2.06 2.25 2.18 1.51 1.28 2.20 2.19 1.97
Histo controls   1.63 1.57 1.97 1.92 1.63 1.46 2.23 2.08 1.81
B. Distribution %           
Cell blocks           
0   1.7 1.7 3.4 3.4 12.8 12.8 0.0 0.9 4.6
0.1   0.0 0.9 0.0 4.3 0.0 19.7 0.0 0.9 3.2
0.5   0.0 1.7 0.0 2.6 0.0 10.2 0.0 5.0 2.4
1   21.4 21.4 13.7 7.6 42.7 13.7 17.9 12.8 18.9
1.5   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1
2   41.9 39.3 37.6 36.8 24.8 23.9 44.5 42.7 36.3
3   35.0 35.0 45.3 45.3 19.7 19.7 37.6 36.8 34.3
Total   100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
C. Score means           
Cell blocks           
Lung Adeno Ca   1.96 1.94 2.22 2.26 1.43 1.35 2.13 2.03 1.92
Breast Ca   1.90 1.61 1.90 1.81 1.60 1.37 1.90 1.65 1.72
Female Genital Tract Ca   2.13 2.13 2.28 2.20 1.72 1.48 2.33 2.29 2.07
Mesothelioma   2.47 2.47 2.40 2.34 1.80 1.53 2.40 2.40 2.23
Gastro-Intestinal Ca   2.33 2.33 1.92 1.83 1.25 1.10 2.00 2.00 1.85
Unknown Primary   1.93 1.86 2.57 2.57 1.21 0.69 2.21 2.11 1.89
Other   1.75 1.63 2.00 2.00 0.50 0.25 1.75 1.63 1.44
Histologic controls           
Lung Adeno Ca   1.10 0.90 1.50 1.40 1.20 0.78 1.70 1.40 1.25
Breast Ca   1.90 1.90 2.00 1.95 1.60 1.50 2.50 2.35 1.96
Female Genital Tract Ca   1.90 1.90 2.40 2.40 2.10 2.10 2.50 2.50 2.23
D. Correlat.ion entities           
Lung AdenoCa p 0.019 0.009 ns ns ns ns ns ns ERCC1 lower
Breast Ca tau 0.186 0.201        Lung Adeno
Female Genital Tract Ca           and Breast Ca
Mesothelioma           
Gastro-Intestinal Ca           
  1. A. Means of intensity and H-scores across cytologic (n = 117) and histologic (n = 30) cores. B. Distributions (%) of score values. C. Means of scores among tumor entities on both cytologic and histologic cores. D. Correlation of ERCC1 scores with tumor entities (Kendall's tau-b test used).